CSI Market
Sign In | Register

Aurinia Pharmaceuticals Inc (AUPH) Annual Balance Sheets

Annual · GAAP · USD millions
Access AUPH quarterly Balance Sheets →
The data below summarizes Aurinia Pharmaceuticals Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent80.16
Marketable Securities0.00
Other Short-term Investments0.00
Cash & Short-term Investments80.00
Accounts receivable41.45
Other Receivables0.70
Inventories0.38
Other Current Assets404.82
Prepaid Expense, Current AS3.13
Total Current Assets491.97
Equipment/Property/Plant Net3.15
Intangible Assets16.62
Long-term investments0.05
Tax Assets, Noncurrent100.88
Other Assets, Noncurrent253.75
Debt Securities Current317.78
Debt Securities Noncurrent-
Operating Lease Right Of Use Asset3.60
Total Assets751.59
Liabilities
Accounts Payable, Current AC66.62
Accrued Liabilities, Current AC66.62
Other Liabilities, Current23.79
Taxes Payable2.01
Total Current Liabilities93.72
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE12.65
Accrued Income Taxes, Noncurrent19.01
Other liabilities, Noncurrent76.53
Contract With Customer Liability Current3.72
Operating Lease Liability Current1.07
Finance Lease Liability Noncurrent52.32
Operating Lease Liability Noncurrent4.90
Total Liabilities170.26
Stockholders' Equity
Common Stock Value1,120.04
Additional Paid In Capital Common Stock111.26
Retained Earnings / Accumulated Deficit-649.37
Accumulated Other Comprehensive Income-0.60
Other Equity-0.60
Common Stockholder's Equity581.33
Total Stockholder's Equity581.33
Liabilities & Stockholder's Equity751.59
4 historic quarters locked

Sign in to unlock the full Aurinia Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Aurinia Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: auph-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001600620-26-000017

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License